First look at neuron–tumor connections in brain illuminates formation and spread of gliomas

by Stephanie Dutchen,Harvard Medical SchoolResearchers revealed which neurons in a mouse brain, shown in red, connect to a human glioma, shown in green. Image: Annie Hsieh. Credit:Proceedi

Updated on: December 20,2024

First look at neuron–tumor connections in brain illuminates formation and spread of gliomas

by Stephanie Dutchen,Harvard Medical SchoolResearchers revealed which neurons in a mouse brain, shown in red, connect to a human glioma, shown in green. Image: Annie Hsieh. Credit:Proceedi

Updated on:December 20,2024

Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects

Updated on: March 25,2025

Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects

Updated on:March 25,2025

Reprogramming compromised immune cells to fight cancer

Updated on: March 27,2025

Reprogramming compromised immune cells to fight cancer

Updated on:March 27,2025

How individual mutations of the tumor suppressor p53 affect pancreatic carcinomas

byUniversity of KonstanzMetabolic profile of p53 mutant variants in pancreatic cancer. Credit:Journal of Experimental & Clinical Cancer Research(2024). DOI: 10.1186/s13046-024-03

Updated on: December 21,2024

How individual mutations of the tumor suppressor p53 affect pancreatic carcinomas

byUniversity of KonstanzMetabolic profile of p53 mutant variants in pancreatic cancer. Credit:Journal of Experimental & Clinical Cancer Research(2024). DOI: 10.1186/s13046-024-03

Updated on:December 21,2024

Cell-based immunotherapy shows promise in early clinical trial for breast cancer

byKent State UniversityBreast imaging of one trial patient before (left image) and after (right image) six weeks of experimental immunotherapy. Note diminution of area of disease (dense white ar

Updated on: December 19,2024

Cell-based immunotherapy shows promise in early clinical trial for breast cancer

byKent State UniversityBreast imaging of one trial patient before (left image) and after (right image) six weeks of experimental immunotherapy. Note diminution of area of disease (dense white ar

Updated on:December 19,2024

Adding polyvinyl alcohol to a boron-containing drug leads to strong antitumor activity in head and neck cancers

byUniversity of TokyoCancer cell during cell division. Credit: National Institutes of HealthTreatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addi

Updated on: December 21,2024

Adding polyvinyl alcohol to a boron-containing drug leads to strong antitumor activity in head and neck cancers

byUniversity of TokyoCancer cell during cell division. Credit: National Institutes of HealthTreatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addi

Updated on:December 21,2024

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on: December 21,2024

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on:December 21,2024

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on: December 20,2024

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on:December 20,2024

AI model achieves high accuracy in skin cancer detection

by TranSpreadThe proposed model architecture. Note: TTA: test-time augmentation. Credit:Data Science and Management(2024). DOI: 10.1016/j.dsm.2024.10.002Led by Aliyu Tetengi Ibrahim and hi

Updated on: January 22,2025

AI model achieves high accuracy in skin cancer detection

by TranSpreadThe proposed model architecture. Note: TTA: test-time augmentation. Credit:Data Science and Management(2024). DOI: 10.1016/j.dsm.2024.10.002Led by Aliyu Tetengi Ibrahim and hi

Updated on:January 22,2025

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024

A pair of enzymes provides insights in how pancreatic cancer cells adapt when resources are scarce

bySanford-Burnham PrebysRepresentative immunohistochemical staining for p-PKCζT560and total PKCζ from clinical samples on a tissue microarray (TMA) containing 152 surgically resected human

Updated on: December 21,2024

A pair of enzymes provides insights in how pancreatic cancer cells adapt when resources are scarce

bySanford-Burnham PrebysRepresentative immunohistochemical staining for p-PKCζT560and total PKCζ from clinical samples on a tissue microarray (TMA) containing 152 surgically resected human

Updated on:December 21,2024

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025